Idiotypic vaccination with a murine anti-dsDNA antibody: Phase I study in patients with nonactive systemic lupus erythematosus with nephritis

Journal of Rheumatology

Volumn 26, Issue 12, 1999, Pages 2602-2608

  Spertini, François ^a   Leimgruber, Annette ^a   Morel, Brigitte ^a   Khazaeli, M B ^b   Yamamoto, Karen ^c   Dayer, Jean Michel ^d   Weisbart, Richard H ^e   Lee, Martin L ^f  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Medclone Inc   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti DNA antibodies; Antiidiotype; Idiotypic vaccination; Lupus nephritis

Indexed keywords

DNA ANTIBODY; DNA VACCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOTHERAPY; MALE; NEPHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION;

ADULT; AGED; ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CREATININE; DNA; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IMMUNOTHERAPY; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MICE; MIDDLE AGED; PLATELET COUNT; SERUM ALBUMIN; TREATMENT OUTCOME; VACCINATION;

EID: 0032707199     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Weinstein A, Bordwell B, Stone B, Tibbetts C, Rothfield NF. Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus. Am J Med 1983;74:206-16.
2. Andrews BS, Lisenberg RA, Theophilopoulos AN, et al. Spontaneous murine lupus-like syndrome: clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-215.
3. Hecht B, Siegel N, Adler M, Kashgarian M, Hayslett PJ. Prognostic indices in lupus nephritis. Medicine 1976;55:163-81.
4. Ebling F, Hahn BH. Restricted subpopulation of DNA antibodies in kidneys of mice with SLE. Comparison of antibodies in serum and renal eluates. Arthritis Rheum 1980;23:392-403.
5. Hahn BH. Characteristics of pathogenic subpopulations of antibodies to DNA. Arthritis Rheum 1982;25:747-52.
6. Ohnishi K, Ebling FM, Mitchell B, Singh RR, Hahn BH, Tsao BP. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural charateristics. Int Immunol 1994;6:817-30.
7. Jacob L, Lety MA, Louvard D, Bach JF. Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. J Clin Invest 1985;75:315-7.
8. Lake RA, Morgan A, Henderson B, Staines NA. A key role for fibronectin in the sequential binding of native DNA antibodies to components of the extracellular matrix: its possible significance in glomerulonephritis. Immunology 1985;54:389-95.
9. Raz E, Ben-Bassl H, Davidi T, Shlomai Z, Eilat D. Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Eur J Immunol 1993;23:383-90.
10. Jeske Zack D, Yamamoto K, Wong AL, Stempniak M, French C, Weisbart RH. DNA mimics of self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus. J Immunol 1995;154:1987-94.
11. Shoenfeld Y, Isenberg D, Rauch J, et al. Idiotypic cross reactions of monoclonal human lupus autoantibodies. J Exp Med 1983; 158-718-30.
12. Hahn BH, Ebling FM. Idiotype restriction in murine lupus: high frequency of three public idiotypes on serum IgG in nephritic NZB/NZW F1 mice. J Immunol 1987;138:2110-8.
13. Hahn BH, Ando D, Ebling FM, et al. T-cell up-regulation of B-cells via their idiotypes contributing to the development of systemic lupus erythematosus. Am J Med 1988;85 Suppl 6A:32-4.
14. Kalunian K, Panosian-Sahakian N, Ebling FM, et al. Idiotypic characteristics of immunoglobulins associated with systemic lupus erythematosus: studies of antibodies deposited in glomeruli of humans. Arthritis Rheum 1989;32:513-22.
15. Paul E, Manheimer-Lory A, Livneh A, et al. Pathogenic anti-DNA antibodies in SLE: idiotypic families and genetic origins. Int Rev Immunol 1990;5:295-313.
16. Hahn B, Ebling F. Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA: possible role of anti-idiotypic antibodies. J Clin Invest 1983;71:1728-36.
17. Hahn BH, Ebling FM. Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA. J Immunol 1984;132:187-90.
18. Zouali M. Jolivet M. Leclerc C. Suppression of murine lupus autoantibodies to DNA by administration of muramyl dipeptide and syngeneic anti-DNA IgG. J Immunol 1985;135:1091-6.
19. Mahana W, Guilbert B, Avrameas S. Suppression of anti-DNA antibody production in MRL mice by treatment with anti-idiotypic antibodies. Clin Exp Immunol 1987;70:538-45.
20. Weisbart RH, Noritake DT, Wong AL, Chan G, Kacena A, Colburn KK. A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus. J Immunol 1990;144:2653-8.
21. Shoenfeld Y, Isenberg D. DNA antibody idiotypes: a review of their genetic, clinical and immunopathologic features. Semin Arthritis Rheum 1987;16:245-52.
22. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
23. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
24. Khazaeli MB. Quantitation of mouse monoclonal antibody and human anti-mouse antibody response in serum of patients. Hybridoma 1989;8:231-9.
25. Teitelbaum D, Rauch J, Stollar BD, Schwartz RS. In vivo effects of antibodies against a high frequency idiotype of anti-DNA antibodies in MRL mice. J Immunol 1984;132:1282-5.
26. Gavalchin J. Seder RA, Datta SK. The NZB × SWR model of lupus nephritis. I. Cross-reactive idiotypes of monoclonal anti-DNA antibodies in relation to antigenic specificity charge and allotype. Identification of interconnected idiotype families inherited from the normal SWR and the autoimmune NZB parents. J Immunol 1987;38:128-37.
27. Klinman DM, Steinberg AD. Idiotypes and auto-immunity. Arthritis Rheum 1986;29:697-705.
28. Waisman A, Mendlovic S, Ruiz PJ, Zinger H, Meshorer A, Mozes E. The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosus. Int Immunol 1993;5:1293-300.
29. Jacob L, Lety MA, Bach JF, Louvard D. Human systemic lupus erythematosus sera contain antibodies against cell-surface protein(s) that share(s) epitope(s) with DNA. Proc Natl Acad Sci USA 1986;83:6970-4.
30. Raz E, Brezis M, Rosenmann E, Eilal D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 1989;142:3076-82.
31. Andre-Schwartz J, Datta SK, Shoenfeld Y, Isenberg A, Stollar BD, Schwartz RS. Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol 1984;31:261-71.
32. Johnston IG. Paladino T, Gurd JW, Brown IR. Molecular cloning glycoprotein showing partial similarity to osteonection/ BM40/SPARC. Neuron 1990;4:165-76.
33. Tracy RP, Schull S, Riggs BI, Mann GK. The osteonectin family of proteins. J Biochem 1988;20:653-60.
34. Engel J, Taylor W, Paulsson M, Sage H, Hogan B. Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonection, and extracellular glycoprotein expressed in mineralized and nonmineralized tissues. Biochemistry 1987;26:6958-65.
35. Battafarano DF, Battafarano NJ, Larsen L, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998;41:1828-34.
36. Klippel JH, Karsh J, Stahl NL, Decker JL, Steinberg AD, Schiffman G. A controlled study of pneumoccocal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 1979;22:1321-5.
37. Williams GW, Steinberg AD, Reinertsen JL, Klassen LW, Decker JL, Dolin R. Influenza immunization in systemic lupus erythematosus. A double-blind trial. Ann Intern Med 1978; 88:729-34.
38. Lipnick RN, Karsh J, Stahl NI, Blackwelder WC, Schiffman G, Klippel JH. Pneumoccocal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol 1985;12:1118-21.
39. Isenberg DA, Dudeney C, Wojharenska F, et al. Detection of cross-reactive anti-DNA idiotypes on tissue bound immunoglobulins from skin biopsies of lupus patients. J Immunol 1985;135:261-4.
40. Isenberg DA, Collin C. Detection of cross reactive anti-DNA antibody idiotypes on renal tissue bound immunoglobulins from lupus patients. J Clin Invest 1985;76:287-94.
41. Avinoach I, Amital-Teplihki H, Kuperman O, Isenberg DA, Shoenfeld Y. Characteristics of antineuronal antibodies in systemic lupus erythematosus patients with and without CNS involvement: the role of mycobacterial cross-reacting antigens. Isr J Med Sci 1990;26:367-73.
42. Hahn BH, Kalunian KC, Fronek Z, et al. Idiotypic characteristics of immunoglobulins associated with human systemic lupus erythematosus. Arthritis Rheum 1990;33:978-84.
43. Mendlovic S, Brocke S, Shoenfeld Y, et al. Induction of a SLE-like disease in mice by a common anti-DNA idiotype. Proc Natl Acad Sci USA 1988;85:2260-4.
44. Blank M, Krup M, Mendlovic S, et al. The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice. Scand J Immunol 1990;31:45-52.
45. Shoenfeld Y, Mozes E. Pathogenic idiotypes of antibodies and autoimmunity: lessons from new experimental models of SLE. FASEB J 1990;4:2646-51.